We are live on ! Find out more
CSBR icon

Champions Oncology
CSBR

32 hedge funds and large institutions have $49.8M invested in Champions Oncology in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

7% more funds holding

Funds holding: 30 → 32 (+2)

0.19% more ownership

Funds ownership: 45.82% → 46.01% (+0.19%)

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

1% less capital invested

Capital invested by funds: $50.4M → $49.8M (-$569K)

Holders
32
Holders Change
+2
Holders Change %
+6.67%
% of All Funds
0.54%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
3
Increased
6
Reduced
6
Closed
–
Calls
$2.24M
Puts
–
Net Calls
+$2.24M
Net Calls Change
+$415K

Top Buyers

Rank Fund Capital Flow
1
TAM
Tocqueville Asset Management
New York
+$261K
2
MAG
Millrace Asset Group
Pennsylvania
+$192K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$10.9K
4
TCWM
Total Clarity Wealth Management
Illinois
+$7.17K
5
BlackRock
BlackRock
New York
+$4.29K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$42.8K
2
Morgan Stanley
Morgan Stanley
New York
-$10.8K
3
Millennium Management
Millennium Management
New York
-$9.58K
4
UBS Group
UBS Group
Switzerland
-$7.82K
5
Ameriprise
Ameriprise
Minnesota
-$6.68K
Name Holding Trade Value Shares
Change 		Change in
Stake
BMC
1
Battery Management Corp
Massachusetts
$19.4M – – –
NMC
2
NEA Management Company
Maryland
$13.7M – – –
MAG
3
Millrace Asset Group
Pennsylvania
$2.83M +$192K +25,061 +8%
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.77M – – –
TAM
5
Tocqueville Asset Management
New York
$2.29M +$261K +34,150 +14%
Renaissance Technologies
6
Renaissance Technologies
New York
$1.31M -$42.8K -5,593 -3%
BlackRock
7
BlackRock
New York
$988K +$4.29K +561 +0.5%
EIM
8
Essex Investment Management
Massachusetts
$921K – – –
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$917K +$10.9K +1,424 +1%
Ameriprise
10
Ameriprise
Minnesota
$681K -$6.68K -873 -1%
OMC
11
Overbrook Management Corp
New York
$511K – – –
ACM
12
ACT Capital Management
Pennsylvania
$500K – – –
Millennium Management
13
Millennium Management
New York
$425K -$9.58K -1,253 -2%
CAM
14
ClariVest Asset Management
California
$386K – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$385K – – –
AC
16
Aristides Capital
Kentucky
$294K – – –
Acadian Asset Management
17
Acadian Asset Management
Massachusetts
$252K – – –
Bank of New York Mellon
18
Bank of New York Mellon
New York
$246K – – –
Northern Trust
19
Northern Trust
Illinois
$218K -$979 -128 -0.5%
State Street
20
State Street
Massachusetts
$215K – – –
HighTower Advisors
21
HighTower Advisors
Illinois
$214K – – –
Citadel Advisors
22
Citadel Advisors
Florida
$134K +$3.96K +518 +3%
ISL
23
Ingalls & Snyder LLC
New York
$88K – – –
GC
24
Globeflex Capital
California
$69K – – –
Morgan Stanley
25
Morgan Stanley
New York
$43K -$10.8K -1,406 -21%
1
2

CSBR Hedge Fund Activity: Q2 2022 in Review

32 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q2 2022, worth a combined $49.8M — down 1.1% from $50.4M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CSBR positions and 0 closed out — a net gain of 3 holders — while 6 added to existing stakes and 6 trimmed.

The largest buyer was Tocqueville Asset Management, adding an estimated $261K. The largest seller was Renaissance Technologies, cutting an estimated $42.8K.

  • 32 institutional investors held Champions Oncology (CSBR) as of Q2 2022, up from 30 in Q1 2022.
  • Funds reported $49.8M of Champions Oncology stock for Q2 2022, down 1.1% quarter-over-quarter.
  • 3 funds opened new Champions Oncology positions in Q2 2022 and 0 closed out, a net change of +3 holders.
  • The largest Champions Oncology buyer in Q2 2022 was Tocqueville Asset Management, an estimated $261K added.
  • The largest Champions Oncology seller in Q2 2022 was Renaissance Technologies, an estimated $42.8K sold.

Based on aggregated 13F filings for Q2 2022.